Article metrics

Download PDFPDF
Extended report
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

 

Online download statistics by month:

Online download statistics by month: December 2013 to June 2020

AbstractFullPdf
Dec 20139144986
Jan 20142596899
Feb 2014824347
Mar 2014994355
Apr 2014992335
May 2014713431
Jun 2014614554
Jul 2014893051
Aug 2014522225
Sep 2014712733
Oct 2014482727
Nov 2014422323
Dec 2014341516
Jan 2015522635
Feb 2015149262209
Mar 201591885136
Apr 20153003465
May 20151723249
Jun 20152464255
Jul 20153784247
Aug 20152941722
Sep 20153243342
Oct 20151511422
Nov 20151662732
Dec 20152522431
Jan 201631586103
Feb 2016792433
Mar 20161391730
Apr 2016692816
May 2016692333
Jun 2016682934
Jul 2016611016
Aug 2016891316
Sep 2016571515
Oct 2016752520
Nov 2016732113
Dec 2016581917
Jan 2017512426
Feb 2017852328
Mar 2017763731
Apr 2017462015
May 2017742129
Jun 20171123419
Jul 20171191828
Aug 20172751221
Sep 20172571920
Oct 20172842022
Nov 20172362920
Dec 20172211617
Jan 20182152418
Feb 20181351714
Mar 20181423222
Apr 20181562614
May 20181471910
Jun 20181351813
Jul 20182741812
Aug 20182001914
Sep 20181592724
Oct 20189774
Nov 20182391915
Dec 20181703515
Jan 20191392015
Feb 20191291511
Mar 20192491412
Apr 20191751617
May 20192852621
Jun 20191611412
Jul 20191731815
Aug 201911897
Sep 20191282114
Oct 20191392014
Nov 20191853115
Dec 20192311716
Jan 20202313817
Feb 2020226249
Mar 20201472111
Apr 20201801413
May 2020173108
Jun 20202051711
Total1499720762362